Feud Intensifies Between ‘Hypocritical’ Planned

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
136
Feud Intensifies Between ‘Hypocritical’
Planned Parenthood and Ousted Physician President
< >

Dr.-Leana-Wen-640x480.png


The public feud between Planned Parenthood and its recently ousted physician president is intensifying as Dr. Leana Wen accuses the left-wing organization of hypocrisy and attempted intimidation.

In a letter to Planned Parenthood’s board of directors that was obtained by the New York Times, the former president and CEO accused the group of holding her health insurance and severance pay as “ransom” until she agreed to sign a confidentiality agreement.

In the letter, Wen reportedly wrote, “I have no desire to file claims against Planned Parenthood for defamation, retaliation, or discrimination,” but then added that the organization was demanding she stop speaking publicly “in exchange for my contractually-guaranteed severance and continued health insurance coverage.”

Wen referred to Planned Parenthood’s actions as “unjust” and “unethical,” said the Times.

The battle between Wen and the abortion giant comes as Planned Parenthood has been more open that abortion is its central priority.

Though, for years, the group insisted abortion was a very small part of the “healthcare” services it provided, ultimately Planned Parenthood opted not to remain in the federal Title X family planning grant program when the Trump administration decided to enforce the program’s rule that grantees of the funds not refer for or perform abortions.

The organization abandoned the program, leaving about $60 million behind in federal funding that will now be redirected to federally qualified healthcare centers that do not perform abortions.

In her letter, Wen reportedly referred to the Trump administration’s Title X rule enforcement as she accused Planned Parenthood’s board of hypocrisy.

“It is deeply hypocritical,” she wrote, that her former organization, “would attempt to enforce a gag order on its immediate past President/CEO while fighting the Trump administration’s gag rule on Title X providers.”

According to the Times, Melanie Newman, senior vice president for communications at Planned Parenthood, said Wen’s accusations are “unfortunate, saddening, and simply untrue.”

“The attorneys representing the board have made every good faith effort to amicably part from Dr. Wen, and are disappointed that they have been unable to reach a suitable resolution regarding her exit package,” she added.

Newman claims Wen received in her severance package a full additional year of salary and health benefits “under terms that are standard and consistent with her employment agreement and any reasonable executive exit package.”

Nevertheless, Wen, who expressed disappointment in a Twitter post that her letter leaked out, said, “There should be no dispute regarding the terms of my employment contract, which are clearly spelled out.”

The ousted president’s tenure at Planned Parenthood lasted less than a year. At the time Wen was hired, the organization announced her as its choice for president with much fanfare that Planned Parenthood would have its first physician president in decades. The group gave the appearance of showing interest in developing its non-abortion services.

When she was suddenly fired in July, Wen at first referred in a tweet to the reason for her ouster as “philosophical differences” with the board, but then elaborated on that reference in a three-page letter to Planned Parenthood colleagues and supporters.

She explained:

One year ago, when I came in front of the Search Committee selecting Planned Parenthood’s next President, I posed this question: Did they see Planned Parenthood as an advocacy organization first, with medical services that are necessary to strengthen its impact, or did they see Planned Parenthood as a health care organization first, with advocacy as a necessary vehicle to protect rights and access?

Wen said she believed she was coming in as Planned Parenthood president to “run a national health care organization and to advocate for the broad range of public health policies that affect our patients’ health.”

“The new Board leadership has determined that the priority of Planned Parenthood moving forward is to double down on abortion rights advocacy,” she said.

According to the Times, Wen said in her letter she believed the best way to protect Planned Parenthood from the Trump administration and states eager to restrict abortion and cut the group’s funding would be to de-emphasize its abortion services.

“However,” she reportedly wrote, “there is a vocal minority,” including many national staff and board members, “who prefer a stridently political, abortion-first philosophy.”

The struggle between Wen and the Planned Parenthood organization became palpable in January after Wen’s interview with BuzzFeed News that was published with the headline, “Planned Parenthood’s New President Wants to Focus on Nonabortion Health Care.”

Following its publication, however, Wen tweeted the headline “completely misconstrue[d] my vision for Planned Parenthood.”

The physician then made what may be the most memorable announcement of her tenure at Planned Parenthood: Abortion is “our core mission.”

After Wen’s ouster, a report at Politico indicated a former Planned Parenthood employee denied the existence of “philosophical differences” between Wen and the board. The anonymous ex-staff member described Wen as an “incompetent manager” who had done significant “damage” to the organization.

At the time of Wen’s ouster, Troy Newman, president of pro-life group Operation Rescue, said the developing feud between Wen and Planned Parenthood was providing the country with “a glimpse of the disarray and division within Planned Parenthood’s ranks.”

“What we are seeing right now is a desperate attempt to regain political power it lost when President Trump took office in 2017,” he added. “They are willing to throw anyone and everyone under the bus to get that power back.”

Currently, Planned Parenthood still receives over $500 million in taxpayer funds as reimbursements through the Medicaid program.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 190

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Everest Group Faces Major Class Action Deadline Looms

Updated Category News Views 218

Everest Group's Headaches Multiply as Deadline Approaches Well, here we find a classic case of Wall Street drama—Everest Group, Ltd. (NYSE:EG), a company whose troubles would make any trader weary. As of late, it's caught up in a nasty class-action lawsuit with stakes high enough to raise eyebrows from Broadway to Bayou. Investors in Everest better be tuned in, because...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 34

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 212

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Sussex County Data Breach Raises Security Concerns

Updated Category News Views 165

The Digital Fiasco: A Wake-Up Call Straight out of Sussex County in good ol' New Jersey, we’re staring down another data breach, folks. When you hear about a data privacy incident, there's always that same sinking feeling of another layer of personal security peeled away. This time, the Sussex County Prosecutor's Office got caught in the crossfire, with personal info...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 219

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 161

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 122

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 187

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading
Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 143

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading

Top 5 Most Recently Viewed Articles

StickIt Technologies Pursues Corporate Restructuring Plan

Updated Category News Views 171

StickIt Technologies Announces Strategic Corporate Moves Vancouver, BC - StickIt Technologies Inc. (the "Company" or "STKT"), a leading parent company of an Israeli technology and cannabinoid firm, has recently made significant strides toward improving its market position. The Company has entered into a non-binding letter of intent ("LOI") aimed at reorganizing its...

Continue Reading
Tricia Quinn Joins Michael Baker International as VP, Enhancing Sectors

Updated Category News Views 383

Tricia Quinn Appointed at Michael Baker International Michael Baker International, a recognized leader in engineering and consulting services, has recently appointed Tricia Quinn, AAIA, MS, as the new Vice President of Aerospace and Healthcare Sectors. With 28 years of extensive leadership experience in both sectors, her role is expected to significantly impact the...

Continue Reading
Exploring Sage Therapeutics: Insights on Their Upcoming Merger

Updated Category News Views 186

Understanding the Merger of Sage Therapeutics Sage Therapeutics, Inc. (NASDAQ: SAGE) is set to engage in a notable transaction with Supernus Pharmaceuticals, Inc. This merger has garnered attention as it proposes significant financial implications for its shareholders. The proposal outlines the sale of Sage Therapeutics, which will see existing shareholders entitled to...

Continue Reading
New Pool Playset: Safe, Fun, Affordable—A Game Changer?

Updated Category News Views 16

Bring the Waterpark Experience Home with JASMINE DREAM POOLS Who needs to shell out a small fortune to take the kids to a waterpark when you can have the fun right in your own backyard? Enter JASMINE DREAM POOLS, a fresh, patent-pending invention designed to jazz up those long summer days with exactly that idea in mind. It's portable, easy to set up, and promises to...

Continue Reading
Houdini II Dares Destiny in High-Flying Live Escape

Updated Category News Views 157

Ready or Not, Appleton Witnesses Magic Under the Stars Jumping into the unknown isn't everyone's cup of tea, let alone doing so while dangling 80 feet high with nothing but air between you and a hard-hitting reality. This is exactly what's on Houdini II's menu for the Society of American Magicians Convention. He's not just juggling risk; he's owning it, in a tribute thick...

Continue Reading